Monalisha Giri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Monalisha Giri has a total of 1 co-authors. Here are the top co-authors by number of shared publications:
- Sagarika Parida
Centurion University of Technology and Management
2 shared publications
Latest Publications
- Open Access
- 7 April 2025
- Published by Defence Scientific Information and Documentation Centre in Defence Life Science Journal
- Vol. 10 (2) , 154-165
Pathophysiology of Dermatophytes and Potent Phytochemical Sources as Possible Applications against Trichophyton Spp.
Trichophyton infections are typically restricted within the epithelial keratinized layer of the skin and therefore grouped among the dermatophytoses. Different species of Trichophyton viz., T. mentagrophytes, T. rubrum and T. violaceum are the important causal agents for the dermatophytic disorders. Azole drugs are extensively employed in the therapeutic practice to treat dermatomycosis. Use of synthetic drugs can cause a number of side effects and may induce drug resistance to the patients. Therefore, plant extracts have been widely investigated as alternative for chemical drugs to solve this problem. Literature data revealed that specific plants showed inhibiting effect against particular species of Trichophyton because of their different phytochemical contents. This study is carried out to document different plant species for their antifungal activity against various species of Trichophyton. Total of 107 plant species belonging to 50 families have been gathered for their antifungal activity against nine species of Trichophyton species viz., T. asahii, T. erinacei, T. inkin, T. ovoides, T. schoenleinii, T. longifusus, T. soudanense, T. tonsurans and T. verrucosum.
- 7 April 2025
- Published by Defence Scientific Information and Documentation Centre in Defence Life Science Journal
- Vol. 10 (2) , 154-165
Open AccessPathophysiology of Dermatophytes and Potent Phytochemical Sources as Possible Applications against Trichophyton Spp.
Trichophyton infections are typically restricted within the epithelial keratinized layer of the skin and therefore grouped among the dermatophytoses. Different species of Trichophyton viz., T. mentagrophytes, T. rubrum and T. violaceum are the important causal agents for the dermatophytic disorders. Azole drugs are extensively employed in the therapeutic practice to treat dermatomycosis. Use of synthetic drugs can cause a number of side effects and may induce drug resistance to the patients. Therefore, plant extracts have been widely investigated as alternative for chemical drugs to solve this problem. Literature data revealed that specific plants showed inhibiting effect against particular species of Trichophyton because of their different phytochemical contents. This study is carried out to document different plant species for their antifungal activity against various species of Trichophyton. Total of 107 plant species belonging to 50 families have been gathered for their antifungal activity against nine species of Trichophyton species viz., T. asahii, T. erinacei, T. inkin, T. ovoides, T. schoenleinii, T. longifusus, T. soudanense, T. tonsurans and T. verrucosum.
- 1 November 2024
- Published by Echo Academic Publishing in Environmental Research and Technology
Antimycotic activity and in-silico validation of bioactive compounds of Roccella montagnei Bél. against clinically isolated onychomycosis fungus Trichophyton mentagrophytes (C.P. Robin) Sabour
Dermatophytes are the most common slow growing contagious agents of cutaneous mycosis and persist as a significant public health issues despite of the availability of a number of antifungal medications. Trichophyton mentagrophytes (C.P. Robin) Sabour. is one of the fungal species which influences the dermatophytic diseases. A wide range of clinical dermatophytosis could infect scalp, face, hand, fingernails, toenails, feet, and also produce jock itch and ring worm of the body. Generally, terbinafine, is used to treat dermatophytosis induced by Trichophyton species. In most of the cases, synthetic anti-mycotic drugs fail over time resulting in development of resistant strains. Sustainable use of herbal sources has been recognised as novel therapeutic drugs to treat dermatophytic disorders. However, few reports are available on antimycotic activity of lichen species. Therefore, in this study, lichen species such as Roccella montagnei Bél was collected from prime locality of Bhubaneswar, Odisha. Antifungal potency of ethanol and methanol extractives of R. montagnei was screened by disc diffusion method against the clinical isolates of T. Mentagrophytes and standard deviation and error was calculated. The overall study resulted with a positive output and validated through in-silico database. Hence the entire study is based on biomedical evaluation and sustainable use of natural plant supplements for the benefit of human society.
- 1 November 2024
- Published by Echo Academic Publishing in Environmental Research and Technology
Antimycotic activity and in-silico validation of bioactive compounds of Roccella montagnei Bél. against clinically isolated onychomycosis fungus Trichophyton mentagrophytes (C.P. Robin) Sabour
Dermatophytes are the most common slow growing contagious agents of cutaneous mycosis and persist as a significant public health issues despite of the availability of a number of antifungal medications. Trichophyton mentagrophytes (C.P. Robin) Sabour. is one of the fungal species which influences the dermatophytic diseases. A wide range of clinical dermatophytosis could infect scalp, face, hand, fingernails, toenails, feet, and also produce jock itch and ring worm of the body. Generally, terbinafine, is used to treat dermatophytosis induced by Trichophyton species. In most of the cases, synthetic anti-mycotic drugs fail over time resulting in development of resistant strains. Sustainable use of herbal sources has been recognised as novel therapeutic drugs to treat dermatophytic disorders. However, few reports are available on antimycotic activity of lichen species. Therefore, in this study, lichen species such as Roccella montagnei Bél was collected from prime locality of Bhubaneswar, Odisha. Antifungal potency of ethanol and methanol extractives of R. montagnei was screened by disc diffusion method against the clinical isolates of T. Mentagrophytes and standard deviation and error was calculated. The overall study resulted with a positive output and validated through in-silico database. Hence the entire study is based on biomedical evaluation and sustainable use of natural plant supplements for the benefit of human society.